Skip to main content
. 2018 Mar 27;10(4):152. doi: 10.3390/v10040152

Figure 2.

Figure 2

Anti-filovirus activities of R. rosea extracts. (a) Six extracts from R. rosea prepared by various extraction methods (Table 1) were evaluated against pseudotyped EBOV infection at 12.5 μg/mL; (b) The in vitro dose-response curves of R. rosea extract are shown against HIV/EBOV (□, red) and HIV/MARV (∆, blue) pseudovirion infections and (c) in cell toxicity assay (□, green) in A549 cells. Data are means ± SD (n = 3) from three independent experiments.